University of Virginia: Melanoma trials

The registry lists 13 Melanoma studies with University of Virginia as lead sponsor. 2 are open to participants now and 2 have results posted.

Early Phase 1 1Phase 1 3Phase 2 5No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Evaluating a Decision Aid for Sentinel Lymph Node Biopsy in Intermediate-Risk MelanomaNot yet recruitingNCT07653087Not applicable
• FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable MelanomaRecruitingNCT06472661Early Phase 1
• Vaccine Therapy in Treating Patients With Metastatic MelanomaCompletedNCT00003224Phase 1Results posted
• Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00003222Phase 2Results posted
• Evaluation Of Mobile Gamma Camera Imaging For Sentinel Node Biopsy In MelanomaCompletedNCT01531608
• Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of MelanomaCompletedNCT01264731Phase 1
• Pilot Study of Infrared Imaging of Cutaneous MelanomaCompletedNCT00937690
• Trial for the Evaluation of the Effect of Systemic Low-dose Interleukin-2 (IL-2) on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With High Risk MelanomaCompletedNCT00928902Phase 2
• A Pilot Study of Intraoperative Gamma Camera Imaging During Sentinel Node Biopsy for MelanomaCompletedNCT00912730
• Evaluation of the Effects of Local Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Adjuvant Administration on Dendritic Cells in Skin of Melanoma Patients and in Sentinel Lymph Nodes: MEL38CompletedNCT00912574Not applicable
• Paclitaxel and GM-CSF in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By SurgerySuspendedNCT00278122Phase 2
• Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV MelanomaCompletedNCT00089219Phase 1/2
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By SurgeryCompletedNCT00089206Phase 2